Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;35(1):188-201.
doi: 10.1038/s41433-020-01191-5. Epub 2020 Oct 7.

Deep learning in glaucoma with optical coherence tomography: a review

Affiliations
Review

Deep learning in glaucoma with optical coherence tomography: a review

An Ran Ran et al. Eye (Lond). 2021 Jan.

Erratum in

Abstract

Deep learning (DL), a subset of artificial intelligence (AI) based on deep neural networks, has made significant breakthroughs in medical imaging, particularly for image classification and pattern recognition. In ophthalmology, applying DL for glaucoma assessment with optical coherence tomography (OCT), including OCT traditional reports, two-dimensional (2D) B-scans, and three-dimensional (3D) volumetric scans, has increasingly raised research interests. Studies have demonstrated that using DL for interpreting OCT is efficient, accurate, and with good performance for discriminating glaucomatous eyes from normal eyes, suggesting that incorporation of DL technology in OCT for glaucoma assessment could potentially address some gaps in the current practice and clinical workflow. However, further research is crucial in tackling some existing challenges, such as annotation standardization (i.e., setting a standard for ground truth labelling among different studies), development of DL-powered IT infrastructure for real-world implementation, prospective validation in unseen datasets for further evaluation of generalizability, cost-effectiveness analysis after integration of DL, the AI "black box" explanation problem. This review summarizes recent studies on the application of DL on OCT for glaucoma assessment, identifies the potential clinical impact arising from the development and deployment of the DL models, and discusses future research directions.

摘要: 深度学习 (DL) 作为基于深层神经网络的人工智能 (AI) 的一个子集, 在医学成像领域, 特别是图像分类和模式识别方面, 已取得重大突破。在眼科领域, 将DL应用于光学相干断层扫描 (OCT), 包括传统的OCT报告、二维B扫描和三维立体扫描, 从而对青光眼进行评估已引发了越来越多的研究兴趣。研究表明, 应用DL对 OCT的结果进行解读是有效、准确的, 并且能很好地区分青光眼和正常眼, 这表明DL技术与OCT结合对青光眼进行评估可弥补当前实践和临床流程中的一些空白。然而, 对于一些现存的挑战, 进一步研究是至关重要的, 例如注释标准化 (即在不同的研究中设定基础事实标签的标准), 为实际应用开发基于DL支持的IT基础架构, 在不可见的数据集中进行前瞻性验证以进一步评估泛化能力, 整合DL后的成本效益分析, 以及AI“黑箱”问题解释。本综述总结了应用DL在OCT评估青光眼的最新研究进展, 确定DL模型的开发和部署所带来的潜在临床影响, 并对未来的研究方向进行了讨论。.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Posterior segment optical coherence tomography (OCT) not only enables the top view of the retina and optic nerve head, but also captures deeper and three-dimensional (3D) view of the morphological features.
a an example of OCT volumetric optic disc scan as well as corresponding en face fundus image generated by line-scanning ophthalmoscopy; b an example of OCT volumetric macula scan as well as corresponding en face fundus image.
Fig. 2
Fig. 2. Illustration of basic process of a deep learning system development and validation.
Usually, a training set is for the network to learn all the features automatically, while a tuning set is a small evaluation set to supervise the real-time performance. A non-overlapping primary validation set (or testing set) is used to test the final performance after training and tuning are done. These three types of sets are usually split from the same one large dataset based on a specific ratio. To further validate model performance on unseen datasets and verify its generalizability, other independent or unseen datasets are needed as external validation sets. A more generally good performance in all validation datasets, including primary and external validations, means higher generalizability of the DL model.
Fig. 3
Fig. 3. There were four categories of deep learning (DL) models with different input.
These input were: (a) OCT measurement images extracted from the traditional OCT report, including retinal nerve fibre layer (RNFL) thickness map, RNFL deviation map, optic disc en face fundus image, ganglion cell with inner plexiform layer (GCIPL) thickness map, GCIPL deviation map, and macula en face fundus image; (b) OCT segmentation-free 2D B-scans; (c) OCT segmentation-free 3D volumetric scans; (d) “Machine-to-Machine” approach to predict OCT quantitative measurements, such as RNFL thickness, GCIPL thickness, and Bruch’s Membrane Opening-based minimum rim width (BMO-MRW), from fundus photographs.
Fig. 4
Fig. 4. A potential clinical workflow with deployment of deep learning-based clinical support system for glaucoma detection with OCT images in primary, secondary and tertiary settings.
Subjects undergo SD-OCT scanning first to screen for glaucoma, and the images will be the input of the AI system. The technicians will then make referral suggestions based on the output (i.e., refer to ophthalmologists due to “Yes GON”, or observation only due to “No GON”).
Fig. 5
Fig. 5. Examples of heatmap generated by class activation map (CAM) for glaucomatous optic neuropathy (GON) detection generated with a previously published DL algorithm [53].
a The cross-sectional view of original OCT optic disc scans, b the en face view of original OCT optic disc scans, and c the corresponding en face fundus image. The feature maps, i.e., the intermediate outputs of the network layers, before the global average pooling layer as well as the parameters of the fully connected layer were taken to obtain the heatmap. The sum of the feature maps weighted by the parameters were taken to generate the CAM. For this particular deep learning model, the red-orange-coloured regions (i.e., retinal nerve fibre layer and neuroretinal rim) have the most discriminative power to differentiate GON.

References

    1. Osborne NN, Wood JPM, Chidlow G, Bae JH, Melena J, Nash MS. Ganglion cell death in glaucoma: what do we really know? Brit J Ophthalmol. 1999;83:980–6. doi: 10.1136/bjo.83.8.980. - DOI - PMC - PubMed
    1. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18:39–57. doi: 10.1016/S1350-9462(98)00014-7. - DOI - PubMed
    1. Nicoara S. The mechanisms of neuronal death in glaucoma. Oftalmologia. 2000;51:4–6. - PubMed
    1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90.. doi: 10.1016/j.ophtha.2014.05.013. - DOI - PubMed
    1. Weinreb RN, Leung CKS, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, et al. Primary open-angle glaucoma. Nat Rev Dis Primers. 2016;2:16067. doi: 10.1038/nrdp.2016.67. - DOI - PubMed